These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16409704)

  • 1. Factors influencing response to ovarian stimulation.
    Keck C; Bassett R; Ludwig M
    Reprod Biomed Online; 2005 Nov; 11(5):562-9. PubMed ID: 16409704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.
    Danhof NA; van Wely M; Repping S; Koks C; Verhoeve HR; de Bruin JP; Verberg MFG; van Hooff MHA; Cohlen BJ; van Heteren CF; Fleischer K; Gianotten J; van Disseldorp J; Visser J; Broekmans FJM; Mol BWJ; van der Veen F; Mochtar MH;
    Hum Reprod; 2018 Oct; 33(10):1866-1874. PubMed ID: 30137325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.
    Balasch J; Fábregues F; Peñarrubia J; Creus M; Manau D; Vidal E; Casamitjana R; Vanrell JA
    Reprod Biomed Online; 2004 Apr; 8(4):408-13. PubMed ID: 15149563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in ovarian stimulation - current concepts and future options.
    Greb RR; Behre HM; Simoni M
    Reprod Biomed Online; 2005 Nov; 11(5):589-600. PubMed ID: 16409708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSH and folliculogenesis: from physiology to ovarian stimulation.
    Vegetti W; Alagna F
    Reprod Biomed Online; 2006 Jun; 12(6):684-94. PubMed ID: 16792843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
    Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
    BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
    Westergaard LG; Yding Andersen C; Erb K; Laursen SB; Rasmussen PE; Rex S; Teisner B
    Reprod Biomed Online; 2004 Jan; 8(1):91-8. PubMed ID: 14759294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
    Howles CM; Alam V; Tredway D; Homburg R; Warne DW
    Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
    Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
    BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the consistency of ovarian stimulation: follitropin alfa filled-by-mass.
    Wikland M; Hugues JN; Howles C
    Reprod Biomed Online; 2006 Jun; 12(6):663-8. PubMed ID: 16792840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.